| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3007145 |
| Definition | An antibiotic-adjuvant admixture of the beta-lactam antibiotic imipenem, beta-lactam potentiator cilastatin, and beta-lactamase inhibitor relebactam. |
| SMILES | N/A |
| AMR Gene Family | PDC beta-lactamase, KPC beta-lactamase |
| Drug Class | penicillin beta-lactam, cephalosporin, carbapenem, monobactam |
| Resistance Mechanism | antibiotic inactivation |
| Classification | 39 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic molecule + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + beta-lactam antibiotic + resistance-modifying agents + inhibitor of antibiotic resistance mechanism + hydrolysis of beta-lactam antibiotic by serine beta-lactamase + penicillin beta-lactam [Drug Class] + beta-lactamase + cephalosporin [Drug Class] + penicillin with extended spectrum + third-generation cephalosporin [Drug Subclass] + second-generation cephalosporin [Drug Subclass] + first-generation cephalosporin [Drug Subclass] + class A beta-lactamase + class C beta-lactamase + beta-lactamase inhibitor + carbapenem [Drug Class] + monobactam [Drug Class] + serine beta-lactamase inhibitor + cefalotin [Antibiotic] + cefixime [Antibiotic] + ampicillin [Antibiotic] + PDC beta-lactamase [AMR Gene Family] + KPC beta-lactamase [AMR Gene Family] + ceftriaxone [Antibiotic] + ceftazidime [Antibiotic] + cefazolin [Antibiotic] + cefoxitin [Antibiotic] + host-related antibiotic adjuvants + diazabicyclooctane + PDC-3 + KPC-4 + KPC-3 + KPC-2 |
| Parent Term(s) | 4 ontology terms | Show + has_part imipenem [Antibiotic] + antibiotic mixture + has_part relebactam [Adjuvant] + has_part cilastatin [Adjuvant] |
| Publications | Zhanel GG, et al. 2018. Drugs 78(1):65-98 Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. (PMID 29230684) Mansour H, et al. 2021. Am J Health Syst Pharm 78(8):674-683 Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination. (PMID 33580649) |
| Curator | Description | Most Recent Edit |
|---|